262 related articles for article (PubMed ID: 32271956)
1. Fetal therapies for cytomegalovirus: What we tell prospective parents.
Bartlett AW; Hamilton ST; Shand AW; Rawlinson WD
Prenat Diagn; 2020 Dec; 40(13):1681-1692. PubMed ID: 32271956
[TBL] [Abstract][Full Text] [Related]
2. Fetal and maternal outcome after hyperimmunoglobulin administration for prevention of maternal-fetal transmission of cytomegalovirus during pregnancy: retrospective cohort analysis.
Seidel V; Hackelöer M; Rancourt RC; Henrich W; Siedentopf JP
Arch Gynecol Obstet; 2020 Dec; 302(6):1353-1359. PubMed ID: 32754858
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis and antenatal management of congenital cytomegalovirus infection.
; Hughes BL; Gyamfi-Bannerman C
Am J Obstet Gynecol; 2016 Jun; 214(6):B5-B11. PubMed ID: 26902990
[TBL] [Abstract][Full Text] [Related]
4. Antenatal treatment options for primary cytomegalovirus infections.
Kagan KO; Sonek J; Hamprecht K
Curr Opin Obstet Gynecol; 2018 Dec; 30(6):355-360. PubMed ID: 30169462
[TBL] [Abstract][Full Text] [Related]
5. Prevention of congenital cytomegalovirus complications by maternal and neonatal treatments: a systematic review.
Hamilton ST; van Zuylen W; Shand A; Scott GM; Naing Z; Hall B; Craig ME; Rawlinson WD
Rev Med Virol; 2014 Nov; 24(6):420-33. PubMed ID: 25316174
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness and safety of prenatal valacyclovir for congenital cytomegalovirus infection: systematic review and meta-analysis.
D'Antonio F; Marinceu D; Prasad S; Khalil A
Ultrasound Obstet Gynecol; 2023 Apr; 61(4):436-444. PubMed ID: 36484439
[TBL] [Abstract][Full Text] [Related]
7. Prevention of maternal and congenital cytomegalovirus infection.
Johnson J; Anderson B; Pass RF
Clin Obstet Gynecol; 2012 Jun; 55(2):521-30. PubMed ID: 22510635
[TBL] [Abstract][Full Text] [Related]
8. New evidence on prognostic features, prevention and treatment of congenital Cytomegalovirus infection.
Sebghati M; Khalil A
Curr Opin Obstet Gynecol; 2020 Oct; 32(5):342-350. PubMed ID: 32739974
[TBL] [Abstract][Full Text] [Related]
9. Valacyclovir in primary maternal CMV infection for prevention of vertical transmission: A case-series.
De Santis M; Apicella M; De Luca C; D'Oria L; Valentini P; Sanguinetti M; Lanzone A; Scambia G; Santangelo R; Masini L
J Clin Virol; 2020 Jun; 127():104351. PubMed ID: 32325395
[TBL] [Abstract][Full Text] [Related]
10. New data on efficacy of valacyclovir in secondary prevention of maternal-fetal transmission of cytomegalovirus.
Egloff C; Sibiude J; Vauloup-Fellous C; Benachi A; Bouthry E; Biquard F; Hawkins-Villarreal A; Houhou-Fidouh N; Mandelbrot L; Vivanti AJ; Picone O
Ultrasound Obstet Gynecol; 2023 Jan; 61(1):59-66. PubMed ID: 35900718
[TBL] [Abstract][Full Text] [Related]
11. Prevention and treatment of fetal cytomegalovirus infection with cytomegalovirus hyperimmune globulin: a multicenter study in Madrid.
Blázquez-Gamero D; Galindo Izquierdo A; Del Rosal T; Baquero-Artigao F; Izquierdo Méndez N; Soriano-Ramos M; Rojo Conejo P; González-Tomé MI; García-Burguillo A; Pérez Pérez N; Sánchez V; Ramos-Amador JT; De la Calle M
J Matern Fetal Neonatal Med; 2019 Feb; 32(4):617-625. PubMed ID: 28978246
[TBL] [Abstract][Full Text] [Related]
12. Case report on early treatment with valaciclovir after maternal primary cytomegalovirus infection.
Codaccioni C; Vauloup-Fellous C; Letamendia E; Saada J; Benachi A; Vivanti AJ
J Gynecol Obstet Hum Reprod; 2019 Apr; 48(4):287-289. PubMed ID: 30634004
[TBL] [Abstract][Full Text] [Related]
13. Cytomegalovirus infection during pregnancy: state of the science.
Leruez-Ville M; Foulon I; Pass R; Ville Y
Am J Obstet Gynecol; 2020 Sep; 223(3):330-349. PubMed ID: 32105678
[TBL] [Abstract][Full Text] [Related]
14. Prevention of Congenital Cytomegalovirus Infection: Review and Case Series of Valaciclovir versus Hyperimmune Globulin Therapy.
Nigro G; Muselli M; On Behalf Of The Congenital Cytomegalic Disease Collaborating Group
Viruses; 2023 Jun; 15(6):. PubMed ID: 37376675
[TBL] [Abstract][Full Text] [Related]
15. Valaciclovir to prevent vertical transmission of cytomegalovirus after maternal primary infection during pregnancy: a randomised, double-blind, placebo-controlled trial.
Shahar-Nissan K; Pardo J; Peled O; Krause I; Bilavsky E; Wiznitzer A; Hadar E; Amir J
Lancet; 2020 Sep; 396(10253):779-785. PubMed ID: 32919517
[TBL] [Abstract][Full Text] [Related]
16. Combined treatment with immunoglobulin and valaciclovir in pregnant women with cytomegalovirus infection and high risk of symptomatic fetal disease.
De la Calle M; Baquero-Artigao F; Rodríguez-Molino P; Cabanes M; Cabrera M; Antolin E; Mellado MJ; Bartha JL
J Matern Fetal Neonatal Med; 2022 Aug; 35(16):3196-3200. PubMed ID: 32933353
[TBL] [Abstract][Full Text] [Related]
17. Maternal-fetal cytomegalovirus infection: from diagnosis to therapy.
Nigro G
J Matern Fetal Neonatal Med; 2009 Feb; 22(2):169-74. PubMed ID: 19253166
[TBL] [Abstract][Full Text] [Related]
18. Secondary prevention of congenital cytomegalovirus infection with valacyclovir following maternal primary infection in early pregnancy.
Faure-Bardon V; Fourgeaud J; Stirnemann J; Leruez-Ville M; Ville Y
Ultrasound Obstet Gynecol; 2021 Oct; 58(4):576-581. PubMed ID: 33998084
[TBL] [Abstract][Full Text] [Related]
19. Screening, prevention, and treatment of congenital cytomegalovirus.
Johnson J; Anderson B
Obstet Gynecol Clin North Am; 2014 Dec; 41(4):593-9. PubMed ID: 25454992
[TBL] [Abstract][Full Text] [Related]
20. Guidelines on CMV congenital infection.
Coll O; Benoist G; Ville Y; Weisman LE; Botet F; Anceschi MM; Greenough A; Gibbs RS; Carbonell-Estrany X;
J Perinat Med; 2009; 37(5):433-45. PubMed ID: 19673682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
